Skip to content
lifestyle.utv.ie
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Medicenna Therapeutics Corp.
Medicenna’s MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026
June 3, 2026
Medicenna Announces the Finalization of the Terms of its Public Offering of Securities
May 19, 2026
Medicenna Announces the Launch of a Marketed Public Offering of Securities
May 13, 2026
Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma
May 12, 2026
←
Previous Page
1
2